SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

Data as of Oct 23
 +0.32 / +4.22%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

SciClone Pharmaceuticals, Inc. is a specialty pharmaceutical company with a product portfolio of therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders. The company operates its business through two segments: China and Rest of the World including United States. Its ZADAXIN product is approved in over 30 countries and used for the treatment of hepatitis B (HBV), hepatitis C (HCV), as a vaccine adjuvant, and certain cancers. SciClone Pharmaceuticals was founded in 1990 and is headquartered in Foster City, CA.

Contact Information

SciClone Pharmaceuticals, Inc.
950 Tower Lane
Foster City California 94404-2125
P:(650) 358-3456
Investor Relations:
(650) 358-1447



Other institutional30.23%
Mutual fund holders28.12%
Individual stakeholders15.41%

Top Executives

Friedhelm BlobelPresident, Chief Executive Officer & Director
Wai-Shun Wilson CheungChief Financial Officer & Senior Vice President
Robert S. KingVice President-Product Development & Manufacturing
Lan XieChief Financial Officer-China Operations
Hong ZhaoChief Executive Officer-China Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.